TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 2,070.00
-100.00 (-4.61%)
Aug 25, 2026, 9:39 AM KST
TELCON RF PHARMACEUTICAL. Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7,962 | 26,125 | 3,306 | 8,519 | 9,734 | 23,195 |
Short-Term Investments | 16,880 | - | 731 | 2,000 | - | - |
Trading Asset Securities | 6,000 | 6,000 | 6,000 | - | - | - |
Cash & Short-Term Investments | 30,842 | 32,125 | 10,037 | 10,519 | 9,734 | 23,195 |
Cash Growth | 222.42% | 220.07% | -4.58% | 8.07% | -58.04% | -6.21% |
Accounts Receivable | 8,291 | 8,100 | 8,738 | 8,991 | 6,139 | 9,479 |
Other Receivables | 1,411 | 870.46 | 242.79 | 177.97 | 267.88 | 224.23 |
Receivables | 23,783 | 17,049 | 9,060 | 16,222 | 6,439 | 9,703 |
Inventory | 4,973 | 5,123 | 4,956 | 5,003 | 4,622 | 4,303 |
Prepaid Expenses | 248.92 | 265.68 | 223.42 | 83.2 | 73.74 | 98.87 |
Other Current Assets | 4,000 | 3,172 | 1,735 | 1,161 | 2,258 | 55.98 |
Total Current Assets | 63,847 | 57,735 | 26,011 | 32,989 | 23,127 | 37,357 |
Property, Plant & Equipment | 9,629 | 9,877 | 11,180 | 8,468 | 8,038 | 9,320 |
Long-Term Investments | 58,620 | 70,213 | 94,886 | 74,800 | 63,375 | 90,287 |
Other Intangible Assets | 15,608 | 16,234 | 18,738 | 21,338 | 23,881 | 30,201 |
Long-Term Accounts Receivable | - | - | - | - | - | -0 |
Other Long-Term Assets | 2,633 | 2,551 | 2,703 | 2,774 | 799.52 | 864.83 |
Total Assets | 150,390 | 156,668 | 153,588 | 140,415 | 119,255 | 168,030 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,748 | 3,142 | 2,818 | 2,581 | 2,668 | 2,630 |
Accrued Expenses | 1,111 | 1,173 | 899.94 | 697.9 | 720.39 | 901.94 |
Short-Term Debt | 38,001 | 32,308 | 54,663 | 26,443 | 28,853 | 53,991 |
Current Portion of Long-Term Debt | 0 | -0 | 0 | 0 | 0 | 0 |
Current Portion of Leases | 512.13 | 527.59 | 437.95 | 577.16 | 694.1 | 644.11 |
Other Current Liabilities | 9,127 | 9,109 | 10,901 | 4,625 | 1,394 | 1,946 |
Total Current Liabilities | 51,500 | 46,259 | 69,720 | 34,924 | 34,329 | 60,113 |
Long-Term Leases | 1,310 | 1,433 | 589.71 | 403.02 | 727.85 | 1,301 |
Other Long-Term Liabilities | 157.74 | 157.61 | 143.39 | 143.41 | 62.77 | 7.91 |
Total Liabilities | 52,967 | 47,850 | 70,453 | 35,470 | 35,120 | 61,422 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 68,524 | 68,524 | 12,025 | 11,599 | 10,860 | 9,991 |
Additional Paid-In Capital | 229,052 | 229,052 | 245,985 | 243,907 | 238,108 | 216,003 |
Retained Earnings | -203,385 | -191,918 | -180,462 | -154,142 | -168,048 | -126,310 |
Treasury Stock | -56.04 | -56.04 | -56.04 | - | - | - |
Comprehensive Income & Other | 2,973 | 2,899 | 5,337 | 3,094 | 3,203 | 6,896 |
Total Common Equity | 97,108 | 108,501 | 82,830 | 104,459 | 84,123 | 106,580 |
Minority Interest | 315.42 | 317.35 | 305.35 | 485.46 | 12.26 | 27.59 |
Shareholders' Equity | 97,423 | 108,818 | 83,135 | 104,945 | 84,135 | 106,608 |
Total Liabilities & Equity | 150,390 | 156,668 | 153,588 | 140,415 | 119,255 | 168,030 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 39,823 | 34,268 | 55,691 | 27,423 | 30,275 | 55,936 |
Net Cash (Debt) | -8,981 | -2,143 | -45,654 | -16,904 | -20,542 | -32,741 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1601.14 | -446.86 | -12869.32 | -3767.91 | -4985.94 | -12423.17 |
Filing Date Shares Outstanding | 6.85 | 6.85 | 3.6 | 3.48 | 3.26 | 3 |
Total Common Shares Outstanding | 6.85 | 6.85 | 3.61 | 3.48 | 3.26 | 3 |
Working Capital | 12,348 | 11,475 | -43,709 | -1,935 | -11,202 | -22,756 |
Book Value Per Share | 14173.42 | 15836.29 | 22960.33 | 30018.29 | 25819.44 | 35559.09 |
Tangible Book Value | 81,499 | 92,267 | 64,092 | 83,121 | 60,242 | 76,379 |
Tangible Book Value Per Share | 11895.30 | 13466.81 | 17766.18 | 23886.39 | 18489.68 | 25482.97 |
Land | 827.37 | 827.37 | 827.37 | 827.37 | 827.37 | 827.37 |
Buildings | 5,407 | 5,407 | 5,576 | 5,281 | 4,974 | 4,867 |
Machinery | 11,255 | 11,858 | 10,720 | 8,702 | 8,016 | 7,927 |
Construction In Progress | 202.77 | 77.6 | 1,027 | - | 325 | 316 |